Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Characterization and diagnostic application of genomic NPM-ALK fusion sequences in anaplastic large-cell lymphoma.

Krumbholz M, Woessmann W, Zierk J, Seniuk D, Ceppi P, Zimmermann M, Singh VK, Metzler M, Damm-Welk C.

Oncotarget. 2018 May 29;9(41):26543-26555. doi: 10.18632/oncotarget.25489. eCollection 2018 May 29.

2.

Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells.

Schwab A, Siddiqui A, Vazakidou ME, Napoli F, Böttcher M, Menchicchi B, Raza U, Saatci Ö, Krebs AM, Ferrazzi F, Rapa I, Dettmer-Wilde K, Waldner MJ, Ekici AB, Rasheed SAK, Mougiakakos D, Oefner PJ, Sahin O, Volante M, Greten FR, Brabletz T, Ceppi P.

Cancer Res. 2018 Apr 1;78(7):1604-1618. doi: 10.1158/0008-5472.CAN-17-2834. Epub 2018 Jan 17.

PMID:
29343522
3.

GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers.

Rasheed SAK, Leong HS, Lakshmanan M, Raju A, Dadlani D, Chong FT, Shannon NB, Rajarethinam R, Skanthakumar T, Tan EY, Hwang JSG, Lim KH, Tan DS, Ceppi P, Wang M, Tergaonkar V, Casey PJ, Iyer NG.

Oncogene. 2018 Mar;37(10):1340-1353. doi: 10.1038/s41388-017-0038-6. Epub 2017 Dec 19.

PMID:
29255247
4.

Relationship of tropospheric stability to climate sensitivity and Earth's observed radiation budget.

Ceppi P, Gregory JM.

Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):13126-13131. doi: 10.1073/pnas.1714308114. Epub 2017 Nov 28.

5.

Thymidylate synthase is functionally associated with ZEB1 and contributes to the epithelial-to-mesenchymal transition of cancer cells.

Siddiqui A, Vazakidou ME, Schwab A, Napoli F, Fernandez-Molina C, Rapa I, Stemmler MP, Volante M, Brabletz T, Ceppi P.

J Pathol. 2017 Jun;242(2):221-233. doi: 10.1002/path.4897.

PMID:
28337746
6.

CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon Response.

Qadir AS, Ceppi P, Brockway S, Law C, Mu L, Khodarev NN, Kim J, Zhao JC, Putzbach W, Murmann AE, Chen Z, Chen W, Liu X, Salomon AR, Liu H, Weichselbaum RR, Yu J, Peter ME.

Cell Rep. 2017 Mar 7;18(10):2373-2386. doi: 10.1016/j.celrep.2017.02.037.

7.

The role of CD95 and CD95 ligand in cancer.

Peter ME, Hadji A, Murmann AE, Brockway S, Putzbach W, Pattanayak A, Ceppi P.

Cell Death Differ. 2015 May;22(5):885-6. doi: 10.1038/cdd.2015.25. No abstract available.

8.

The role of CD95 and CD95 ligand in cancer.

Peter ME, Hadji A, Murmann AE, Brockway S, Putzbach W, Pattanayak A, Ceppi P.

Cell Death Differ. 2015 Apr;22(4):549-59. doi: 10.1038/cdd.2015.3. Epub 2015 Feb 6. Review. Erratum in: Cell Death Differ. 2015 May;22(5):885-6.

9.

CD95 and CD95L promote and protect cancer stem cells.

Ceppi P, Hadji A, Kohlhapp FJ, Pattanayak A, Hau A, Liu X, Liu H, Murmann AE, Peter ME.

Nat Commun. 2014 Nov 4;5:5238. doi: 10.1038/ncomms6238.

10.

Death induced by CD95 or CD95 ligand elimination.

Hadji A, Ceppi P, Murmann AE, Brockway S, Pattanayak A, Bhinder B, Hau A, De Chant S, Parimi V, Kolesza P, Richards J, Chandel N, Djaballah H, Peter ME.

Cell Rep. 2014 Apr 10;7(1):208-22. doi: 10.1016/j.celrep.2014.02.035. Epub 2014 Mar 20.

11.

Prognostic role of bone sialoprotein in clear cell renal carcinoma.

Righi L, Bollito E, Ceppi P, Mirabelli D, Tavaglione V, Chiusa L, Porpiglia F, Brunelli M, Martignoni G, Terrone C, Papotti M.

Anticancer Res. 2013 Jun;33(6):2679-87.

PMID:
23749927
12.

MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells.

Ceppi P, Peter ME.

Oncogene. 2014 Jan 16;33(3):269-78. doi: 10.1038/onc.2013.55. Epub 2013 Mar 4. Review.

PMID:
23455327
13.

CD95 is part of a let-7/p53/miR-34 regulatory network.

Hau A, Ceppi P, Peter ME.

PLoS One. 2012;7(11):e49636. doi: 10.1371/journal.pone.0049636. Epub 2012 Nov 14.

14.

Differentiation-inducing factor-1 enhances 5-fluorouracil action on oral cancer cells inhibiting E2F1 and thymidylate synthase mRNAs accumulation.

Sprio AE, Di Scipio F, Ceppi P, Salamone P, Di Carlo F, Scagliotti GV, Papotti M, Ceccarelli A, Berta GN.

Cancer Chemother Pharmacol. 2012 Apr;69(4):983-9. doi: 10.1007/s00280-011-1790-x. Epub 2011 Dec 4.

PMID:
22139443
15.

Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation.

Lo Iacono M, Monica V, Saviozzi S, Ceppi P, Bracco E, Papotti M, Scagliotti GV.

J Transl Med. 2011 Jun 30;9:100. doi: 10.1186/1479-5876-9-100.

16.

MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer.

Kumarswamy R, Mudduluru G, Ceppi P, Muppala S, Kozlowski M, Niklinski J, Papotti M, Allgayer H.

Int J Cancer. 2012 May 1;130(9):2044-53. doi: 10.1002/ijc.26218. Epub 2011 Aug 8.

17.

Expression and pharmacological inhibition of thymidylate synthase and Src kinase in nonsmall cell lung cancer.

Ceppi P, Rapa I, Lo Iacono M, Righi L, Giorcelli J, Pautasso M, Billè A, Ardissone F, Papotti M, Scagliotti GV.

Int J Cancer. 2012 Apr 15;130(8):1777-86. doi: 10.1002/ijc.26188. Epub 2011 Aug 5.

18.

Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer.

Mudduluru G, Ceppi P, Kumarswamy R, Scagliotti GV, Papotti M, Allgayer H.

Oncogene. 2011 Jun 23;30(25):2888-99. doi: 10.1038/onc.2011.13. Epub 2011 Feb 14.

PMID:
21317930
19.

p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.

Lo Iacono M, Monica V, Saviozzi S, Ceppi P, Bracco E, Papotti M, Scagliotti GV.

J Thorac Oncol. 2011 Mar;6(3):473-81. doi: 10.1097/JTO.0b013e31820b86b0.

20.

Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer.

Ceppi P, Mudduluru G, Kumarswamy R, Rapa I, Scagliotti GV, Papotti M, Allgayer H.

Mol Cancer Res. 2010 Sep;8(9):1207-16. doi: 10.1158/1541-7786.MCR-10-0052. Epub 2010 Aug 9.

21.

Emerging role of thymidylate synthase for the pharmacogenomic selection of patients with thoracic cancer.

Ceppi P, Monica V, Righi L, Papotti M, Scagliotti GV.

Int J Clin Pharmacol Ther. 2010 Jul;48(7):481-2. No abstract available.

PMID:
20557852
22.

New strategies for targeting the therapy of NSCLC: the role of ERCC1 and TS.

Ceppi P, Papotti M, Scagliotti G.

Adv Med Sci. 2010;55(1):22-5. doi: 10.2478/v10039-010-0017-4. Review.

PMID:
20494871
23.

Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy.

Righi L, Papotti MG, Ceppi P, Billè A, Bacillo E, Molinaro L, Ruffini E, Scagliotti GV, Selvaggi G.

J Clin Oncol. 2010 Mar 20;28(9):1534-9. doi: 10.1200/JCO.2009.25.9275. Epub 2010 Feb 22.

PMID:
20177021
24.

Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung.

Monica V, Scagliotti GV, Ceppi P, Righi L, Cambieri A, Lo Iacono M, Saviozzi S, Volante M, Novello S, Papotti M.

Clin Cancer Res. 2009 Dec 15;15(24):7547-7552.

25.

Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin.

Ceppi P, Papotti M, Monica V, Lo Iacono M, Saviozzi S, Pautasso M, Novello S, Mussino S, Bracco E, Volante M, Scagliotti GV.

Mol Cancer Ther. 2009 Nov;8(11):3066-74. doi: 10.1158/1535-7163.MCT-09-0151. Epub 2009 Oct 27.

26.

Obestatin in human neuroendocrine tissues and tumours: expression and effect on tumour growth.

Volante M, Rosas R, Ceppi P, Rapa I, Cassoni P, Wiedenmann B, Settanni F, Granata R, Papotti M.

J Pathol. 2009 Aug;218(4):458-66. doi: 10.1002/path.2551.

PMID:
19373849
27.

Updated clinical information on multitargeted antifolates in lung cancer.

Scagliotti GV, Ceppi P, Capelletto E, Novello S.

Clin Lung Cancer. 2009 Mar;10 Suppl 1:S35-40. doi: 10.3816/CLC.2009.s.006. Review.

PMID:
19362945
28.

Non-small cell lung cancer exhibits transcript overexpression of genes associated with homologous recombination and DNA replication pathways.

Saviozzi S, Ceppi P, Novello S, Ghio P, Lo Iacono M, Borasio P, Cambieri A, Volante M, Papotti M, Calogero RA, Scagliotti GV.

Cancer Res. 2009 Apr 15;69(8):3390-6. doi: 10.1158/0008-5472.CAN-08-2981. Epub 2009 Apr 7.

29.

Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung.

Monica V, Ceppi P, Righi L, Tavaglione V, Volante M, Pelosi G, Scagliotti GV, Papotti M.

Mod Pathol. 2009 May;22(5):709-17. doi: 10.1038/modpathol.2009.30. Epub 2009 Mar 13.

30.

Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy.

Ceppi P, Novello S, Cambieri A, Longo M, Monica V, Lo Iacono M, Giaj-Levra M, Saviozzi S, Volante M, Papotti M, Scagliotti G.

Clin Cancer Res. 2009 Feb 1;15(3):1039-45. doi: 10.1158/1078-0432.CCR-08-1227.

31.

Prognostic role of osteopontin expression in malignant pleural mesothelioma.

Cappia S, Righi L, Mirabelli D, Ceppi P, Bacillo E, Ardissone F, Molinaro L, Scagliotti GV, Papotti M.

Am J Clin Pathol. 2008 Jul;130(1):58-64. doi: 10.1309/TWCQV536WWRNEU51.

PMID:
18550471
32.

Excision repair cross complementing-1 and topoisomerase IIalpha gene expression in small-cell lung cancer patients treated with platinum and etoposide: a retrospective study.

Ceppi P, Longo M, Volante M, Novello S, Cappia S, Bacillo E, Selvaggi G, Saviozzi S, Calogero R, Papotti M, Scagliotti GV.

J Thorac Oncol. 2008 Jun;3(6):583-9. doi: 10.1097/JTO.0b013e3181734f24.

33.

Human ASH1 expression in prostate cancer with neuroendocrine differentiation.

Rapa I, Ceppi P, Bollito E, Rosas R, Cappia S, Bacillo E, Porpiglia F, Berruti A, Papotti M, Volante M.

Mod Pathol. 2008 Jun;21(6):700-7. doi: 10.1038/modpathol.2008.39. Epub 2008 Feb 29.

34.

Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors.

Ceppi P, Volante M, Ferrero A, Righi L, Rapa I, Rosas R, Berruti A, Dogliotti L, Scagliotti GV, Papotti M.

Clin Cancer Res. 2008 Feb 15;14(4):1059-64. doi: 10.1158/1078-0432.CCR-07-1513.

35.

Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.

Volante M, Saviozzi S, Rapa I, Ceppi P, Cappia S, Calogero R, Novello S, Borasio P, Papotti M, Scagliotti GV.

Cancer. 2007 Sep 15;110(6):1321-8.

36.

ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine.

Ceppi P, Volante M, Novello S, Rapa I, Danenberg KD, Danenberg PV, Cambieri A, Selvaggi G, Saviozzi S, Calogero R, Papotti M, Scagliotti GV.

Ann Oncol. 2006 Dec;17(12):1818-25. Epub 2006 Sep 15.

PMID:
16980606
37.

Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase.

Ceppi P, Volante M, Saviozzi S, Rapa I, Novello S, Cambieri A, Lo Iacono M, Cappia S, Papotti M, Scagliotti GV.

Cancer. 2006 Oct 1;107(7):1589-96.

38.

Two tail-anchored protein variants, differing in transmembrane domain length and intracellular sorting, interact differently with lipids.

Ceppi P, Colombo S, Francolini M, Raimondo F, Borgese N, Masserini M.

Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16269-74. Epub 2005 Oct 28. Erratum in: Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17580.

39.

Proteomics of plasma membrane microdomains.

Raimondo F, Ceppi P, Guidi K, Masserini M, Foletti C, Pitto M.

Expert Rev Proteomics. 2005 Oct;2(5):793-807. Review.

PMID:
16209657

Supplemental Content

Support Center